{"id":"W4382011805","doi":"10.1002/ajh.27007","title":"Classification of accelerated phase chronic myeloid leukemia in the era of the <scp>BCR</scp>::<scp>ABL1</scp> tyrosine kinase inhibitors: A work in progress","year":2023,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Canada; Ascentage Pharma; British Mycological Society; Novartis","keywords":"Myeloid leukemia; Tyrosine kinase; Cancer research; Medicine; Internal medicine; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00161946,0.0007061655,0.002885432,0.0008473077,0.00008052172,0.0000331954,0.00122952,0.0007743356,0.00001569556],"category_scores_gemma":[0.006827075,0.0004522725,0.0005269475,0.003700227,0.001688246,0.0001491411,0.00019454,0.003752456,0.00001701221],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004149049,"about_ca_system_score_gemma":0.009951271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004221708,"about_ca_topic_score_gemma":0.0001899462,"domain_scores_codex":[0.9929464,0.00106048,0.002887683,0.0006125309,0.00157352,0.0009193943],"domain_scores_gemma":[0.9861498,0.006253105,0.005438193,0.001131171,0.0008286471,0.0001990503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006942964,0.002135168,0.01888849,0.00124889,0.00108444,0.001691375,0.005353426,0.0001284643,0.002889188,0.00005991734,0.951512,0.01431434],"study_design_scores_gemma":[0.1199702,0.03212721,0.08731573,0.05138699,0.005728558,0.005398797,0.03458574,0.001068166,0.04280904,0.0003894539,0.6182408,0.0009793116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9095597,0.005373745,0.000007969921,0.0006106712,0.08297219,0.001255954,0.00008008154,0.0000302081,0.0001095382],"genre_scores_gemma":[0.937661,0.001934299,0.0002855626,0.00007555718,0.05925719,0.0001910379,0.0002287969,0.0001876779,0.0001789064],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3332712,"threshold_uncertainty_score":0.9997929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01785556490048358,"score_gpt":0.3096090825842296,"score_spread":0.2917535176837461,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}